A network biology approach evaluating the anticancer effects of bortezomib identifies SPARC as a therapeutic target in adult T-cell leukemia cells

by Yu Zhang, Chiaki Kobayashi, Ryoko Hamamura, Junko H Ohyashiki, Kazuma Ohyashiki
Published 2008-10-01

Low body weight and body mass index may be associated with musculoskeletal pain following imatinib discontinuation in chronic myeloid leukemia

by Seiichiro Katagiri, Tetsuzo Tauchi, Keiko Ando, Seiichi Okabe, Moritaka Gotoh, Kazuma Ohyashiki
Published 2017-01-01

Chromatin Regulation by HP1γ Contributes to Survival of 5-Azacytidine-Resistant Cells

by Satoshi Imanishi, Tomohiro Umezu, Chiaki Kobayashi, Tomohiko Ohta, Kazuma Ohyashiki, Junko H. Ohyashiki
Published 2018-10-01

Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients.

by Masami Tanaka, Kosuke Oikawa, Masakatsu Takanashi, Motoshige Kudo, Junko Ohyashiki, Kazuma Ohyashiki, Masahiko Kuroda
Published 2009-01-01

Combining the ABL1 kinase inhibitor ponatinib and the histone deacetylase inhibitor vorinostat: a potential treatment for BCR-ABL-positive leukemia.

by Seiichi Okabe, Tetsuzo Tauchi, Shinya Kimura, Taira Maekawa, Toshihiko Kitahara, Yoko Tanaka, Kazuma Ohyashiki
Published 2014-01-01

Expression Profile of a γ-Deletion Variant of the Human Telomerase Reverse Transcriptase Gene

by Hisashi Hisatomi, Kazuma Ohyashiki, Junko H. Ohyashiki, Kumi Nagao, Taichi Kanamaru, Hiroyuki Hirata, Nozomu Hibi, Yutaka Tsukada
Published 2003-05-01

Exosomal miRNA Signatures for Late-Onset Acute Graft-Versus-Host Disease in Allogenic Hematopoietic Stem Cell Transplantation

by Seiichiro Yoshizawa, Tomohiro Umezu, Yuu Saitoh, Moritaka Gotoh, Daigo Akahane, Chiaki Kobayashi, Junko H. Ohyashiki, Kazuma Ohyashiki
Published 2018-08-01

Downregulation of Plasma miR-215 in Chronic Myeloid Leukemia Patients with Successful Discontinuation of Imatinib

by Kazuma Ohyashiki, Tomohiro Umezu, Seiichiro Katagiri, Chiaki Kobayashi, Kenko Azuma, Tetsuzo Tauchi, Seiichi Okabe, Yutaka Fukuoka, Junko H. Ohyashiki
Published 2016-04-01

Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma.

by Kazuma Ohyashiki, Tomohiro Umezu, Sei-Ichiro Yoshizawa, Yoshikazu Ito, Michiyo Ohyashiki, Hisashi Kawashima, Masami Tanaka, Masahiko Kuroda, Junko H Ohyashiki
Published 2011-02-01

Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm

by Sho Kubota, Kenji Tokunaga, Tomohiro Umezu, Takako Yokomizo-Nakano, Yuqi Sun, Motohiko Oshima, Kar Tong Tan, Henry Yang, Akinori Kanai, Eisaku Iwanaga, Norio Asou, Takahiro Maeda, Naomi Nakagata, Atsushi Iwama, Kazuma Ohyashiki, Motomi Osato, Goro Sashida
Published 2019-04-01

Author Correction: Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm

by Sho Kubota, Kenji Tokunaga, Tomohiro Umezu, Takako Yokomizo-Nakano, Yuqi Sun, Motohiko Oshima, Kar Tong Tan, Henry Yang, Akinori Kanai, Eisaku Iwanaga, Norio Asou, Takahiro Maeda, Naomi Nakagata, Atsushi Iwama, Kazuma Ohyashiki, Motomi Osato, Goro Sashida
Published 2019-08-01

Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia

by Yotaro Ochi, Kenichi Yoshida, Ying-Jung Huang, Ming-Chung Kuo, Yasuhito Nannya, Ko Sasaki, Kinuko Mitani, Noriko Hosoya, Nobuhiro Hiramoto, Takayuki Ishikawa, Susan Branford, Naranie Shanmuganathan, Kazuma Ohyashiki, Naoto Takahashi, Tomoiku Takaku, Shun Tsuchiya, Nobuhiro Kanemura, Nobuhiko Nakamura, Yasunori Ueda, Satoshi Yoshihara, Rabindranath Bera, Yusuke Shiozawa, Lanying Zhao, June Takeda, Yosaku Watatani, Rurika Okuda, Hideki Makishima, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Masashi Sanada, Akifumi Takaori-Kondo, Satoru Miyano, Seishi Ogawa, Lee-Yung Shih
Published 2021-05-01